Fortnightly Review: Ten years of natriuretic peptide research: A new dawn for their diagnostic and therapeutic use?

BMJ

Volumn 308, Issue 6944, 1994, Pages 1615-

  Struthers, A D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOPEPTIDASE INHIBITOR; ENZYME INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; HEART FAILURE; HUMAN; HYPERTENSION; MEDICAL EDUCATION; MEDICAL RESEARCH; NATRIURESIS; PRIORITY JOURNAL; REVIEW; VASODILATATION;

AMINO ACID SEQUENCE; ATRIAL NATRIURETIC FACTOR; HEART DISEASES; HEART FAILURE, CONGESTIVE; HUMAN; HYPERTENSION; MOLECULAR SEQUENCE DATA; PROTEASE INHIBITORS;

EID: 0028318312     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.308.6944.1615     Document Type: Article

References (34)

1. De Bold AJ Borenstein HB Veress AT Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89–94.
2. Kangawa H Marsuo H. Purification and complete amino acid sequence of alpha human atrial natriuretic polypeptide (alpha-h ANP). Biochem Biophys Res Commun 1984; 118: 131–9.
3. Sudoh T Kangawa K Minamino N Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78–81.
4. Sudoh T Minamino N Kangawa K Matsuo H. C-type natriuretic peptide: a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990; 168: 863–70.
5. Nakao K Ogawa Y Suga S Imura H. Molecular biology and biochemistry of the natriuretic peptide system. I. Natriuretic peptides. J Hypertens 1992; 10: 907–12.
6. Jamison RL Canaan-Kuhl S Pratt R. The natriuretic peptides and their receptors. Am J Kidney Dis 1992; 20: 519–30.
7. Davidson N Struthers AD. Brain natriuretic peptide. J Hypertens 1994; 12: 329–36.
8. Lang CC Struthers AD. Atrial and brain natriuretic peptides - a dual natriuretic peptide system potentially involved in circulatory homoeostasis. Clin Sci 1992; 83: 519–27.
9. Struthers AD. Plasma concentrations of BNP: will this test reduce the need for cardiac investigations? Br Heart J 1993; 70: 397–8.
10. Wheedon NM MacDonald T Flucker CJ McKendrick A McDevitt D Struthers AD. Echocardiography in chronic heart failure in the community. QJ Med 1993; 86: 17–24.
11. Lerman A Gibbons RJ Rodeheffer RJ Bailey KR McKinley LJ Heublein DM Burnett JC. Circulating N-terminal ANP as a marker for symptomless left ventricular dysfunction. Lancet 1993; 341: 1105–8.
12. Motwani JG McAlpine H Kennedy N Struthers AD. Plasma BNP as an indicator for ACE inhibition after myocardial infarction. Lancet 1993; 341: 1109–13.
13. Hu DCK Wong EFC Wong NLM. The differential response in ANF release during exercise in patients with and without ischemic heart disease. Am J Med Sci 1988; 296: 111–3.
14. Yoshibayashi M Kamiya T Saito Y Matsuo H. Increased plasma levels of BNP in hypertrophic cardiomyopathy. N Engl J Med 1993; 329: 433–4.
15. Wilkins MR Unwin RJ Kenny AJ. Endopeptidase 24.11 and its inhibitors: potential therapeutic agents for edematous disorders and hypertension. Kidney Int 1993; 43: 273–85.
16. Bevan EG Connell JMC Doyle J Carmichael HA Davies DL Lorimer AR McInnes GT. Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension. J Hypertens 1992; 10: 607–13.
17. Kugiyama K Sugiyama S Ohgushi M Matsumura T Yasue H. Suppression of atherosclerotic changes in cholesterol fed rabbits treated with an oral inhibitor of neutral endopeptidase. Circulation 1993; 88: I-521.
18. Itoh H Pratt RE Ohno M Dzau VJ. Atrial natriuretic factor as a novel antigrowth factor in endothelial cells. Hypertension 1992; 19: 758–61.
19. Davis HR McGregor D Hoos L Mullins DE Sybertz EJ. ANF and the neutral endopeptidase inhibitor SCH 42495 prevent myointimal proliferation after vascular injury. Circulation 1992; 86(4): I-220.
20. Monopoli M Forliani A Ongini E. Chronic inhibition of neutral endopeptidase reduces LV hypertrophy without changing BP in spontaneously hypertensive rats. J Hypertens 1991; 9: S246–7.
21. Northridge DB Alabaster CT Connell JMC Dilly SG Lever AF Jardine AG etal.Effects of UK 69578: a novel atriopeptidase inhibitor.Lancet 1989 ii:591–3.
22. Northridge DB Jackson NC Metcalfe MJ McFarlane N Dargie H. Effects of candoxatril, a novel endopeptidase inhibitor compared to frusemide in mild chronic heart failure. Br J Clin Pharmacol 1991; 32: 645.
23. van den Meiracker AH Manin't Veld AJ Admiraal PJJ van Eck HJ Boomsma F Derkx FHM, et al. Partial escape of ACE inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response? J Hypertens 1992; 10: 803–12.
24. SOLVD Investigators. Effect of analapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293–302.
25. Cambien F Poirier O Lecerf L Evans A Cambou JP Arveiler D, et al. Deletion polymorphism in the gene for ACE is a potent risk factor for myocardial infarction. Nature 1992; 359: 641–4.
26. Alderman MH Maddhaven S Ooi WL Cohen H Sealey JE Laragh JH. Association of the renin-sodium profile with the risk of MI in hypertension. N Engl J Med 1991; 324: 1098–104.
27. SAVE Investigators. Effect of captopril on mortality and morbidity in patients with LV dysfunction after MI. N Engl J Med 1992; 327: 669–77.
28. Pacher R Globits S Bergler-Klein J Teufelsbauer H Wutte M Baumgartner W, et al. Clinical and neurohumoral response to patients with severe CHF treated with two different captopril dosages. Eur Heart J 1993; 14: 273–8.
29. Chu A Morris KG Kuehl WD Cusma J Navetta F Cobb FR. Effects of ANP on the coronary arterial vasculature in humans. Circulation 1989; 80: 1627–35.
30. Tanaka H Yasue H Yoshimura M Marita E Jougasaki M Kato H, et al. Suppression of hyperventilation induced attacks with infusion of ANP in patients with variant angina pectoris. Am J Cardiol 1993; 72: 128–33.
31. Lang CC Henderson IS MacTier RA Stewart WK Struthers AD. ANF improves renal function and lowers systolic BP in renal allograft recipients treated with cyclosporin A. J Hypertens 1992; 10: 483–8.
32. Lang CC Choy AM Pringle TH McNeill GP McAlpine H Sturrock NDC, et al. Renal hemodynamic and neurohormonal effects of ANF in cardiac allograft recipients treated with cyclosporin A. Am J Cardiol 1993; 14: 1083–4.
33. Lipkin D Dawny ABS Harwood SM Jackson NC Cattell WR Raine AEG. Enhanced natriuretic effects of acute NEP inhibition in chronic renal failure. J Am Soc Nephrol 1992; 3(3):440.
34. Cargill R Lipworth BJ.Pulmonary vasorelaxant activity of ANP and BNP in man. Br J Clin Pharmacol (in press).